Banque Cantonale Vaudoise’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $378K | Sell |
2,489
-73
| -3% | -$11.1K | 0.02% | 472 |
|
|
2025
Q1 | $386K | Buy |
+2,562
| New | +$386K | 0.02% | 482 |
|
|
2024
Q3 | $425K | Sell |
2,159
-73
| -3% | -$14.4K | 0.02% | 406 |
|
|
2024
Q2 | $461K | Buy |
2,232
+215
| +11% | +$44.4K | 0.02% | 447 |
|
|
2024
Q1 | $547K | Buy |
2,017
+126
| +7% | +$34.2K | 0.02% | 415 |
|
|
2023
Q4 | $447K | Sell |
1,891
-820
| -30% | -$194K | 0.02% | 463 |
|
|
2023
Q3 | $532K | Sell |
2,711
-44
| -2% | -$8.63K | 0.03% | 471 |
|
|
2023
Q2 | $579K | Buy |
2,755
+191
| +7% | +$40.1K | 0.03% | 460 |
|
|
2023
Q1 | $517K | Sell |
2,564
-27
| -1% | -$5.44K | 0.03% | 442 |
|
|
2022
Q4 | $565K | Buy |
2,591
+36
| +1% | +$7.85K | 0.03% | 421 |
|
|
2022
Q3 | $502K | Sell |
2,555
-31
| -1% | -$6.09K | 0.03% | 479 |
|
|
2022
Q2 | $553K | Sell |
2,586
-41
| -2% | -$8.77K | 0.03% | 466 |
|
|
2022
Q1 | $746K | Sell |
2,627
-2,263
| -46% | -$643K | 0.03% | 458 |
|
|
2021
Q4 | $1.84M | Sell |
4,890
-380
| -7% | -$143K | 0.07% | 259 |
|
|
2021
Q3 | $2.18M | Buy |
5,270
+244
| +5% | +$101K | 0.09% | 212 |
|
|
2021
Q2 | $1.86M | Buy |
5,026
+2,268
| +82% | +$839K | 0.08% | 247 |
|
|
2021
Q1 | $799K | Sell |
2,758
-566
| -17% | -$164K | 0.04% | 423 |
|
|
2020
Q4 | $831K | Buy |
3,324
+433
| +15% | +$108K | 0.05% | 347 |
|
|
2020
Q3 | $655K | Buy |
2,891
+35
| +1% | +$7.93K | 0.04% | 367 |
|
|
2020
Q2 | $498K | Buy |
2,856
+275
| +11% | +$48K | 0.04% | 387 |
|
|
2020
Q1 | $326K | Sell |
2,581
-250
| -9% | -$31.6K | 0.03% | 483 |
|
|
2019
Q4 | $432K | Buy |
+2,831
| New | +$432K | 0.03% | 516 |
|